Aggregation Pathways and Biologic Stability Challenges
Aggregation Pathways and Biologic Stability Challenges Understanding Aggregation Pathways and Overcoming Stability Challenges in Biopharmaceuticals Aggregation is one of the most common and critical stability issues in biopharmaceuticals. Protein-based drugs are inherently prone to physical degradation, and aggregation can severely impact product quality, safety, and efficacy. This tutorial provides a step-by-step overview of aggregation pathways,…
Read More “Aggregation Pathways and Biologic Stability Challenges” »